| Date Filed | Type | Description |
| 10/03/2023 |
3
| Mathias Sheila (Chief Scientific Officer) has filed a Form 3 on Virpax Pharmaceuticals, Inc. |
| 08/16/2023 |
4/A
| Shah Vinay (CFO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.99, valued at
$99k
|
|
| 04/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/07/2023 |
4/A
| Mack Anthony P. (CEO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 125,000 options to buy
@ $0.867, valued at
$108.4k
|
|
| 01/27/2023 |
4
| Gudin Jeffrey (Chief Medical Officer) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 options to buy
@ $0.788, valued at
$39.4k
|
|
| 01/27/2023 |
4
| Mack Anthony P. (CEO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 125,000 options to buy
@ $0.788, valued at
$98.5k
|
|
| 01/27/2023 |
4
| Chipman Christopher Michael (CFO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 112,000 options to buy
@ $0.788, valued at
$88.3k
|
|
| 01/04/2023 |
4
| Jambulingam Thani (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.622, valued at
$24.9k
|
|
| 01/04/2023 |
4
| Floyd Eric (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 45,000 options to buy
@ $0.622, valued at
$28k
|
|
| 01/04/2023 |
4
| Sendrow Jerrold (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 35,000 options to buy
@ $0.622, valued at
$21.8k
|
|
| 01/04/2023 |
4
| Dubin Michael F (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.622, valued at
$12.4k
|
|
| 01/04/2023 |
4
| Singh Vanila (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $0.622, valued at
$9.3k
|
|
| 05/26/2022 |
4
| Sendrow Jerrold (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Bought 4,500 shares
@ $1.29, valued at
$5.8k
|
|
| 05/20/2022 |
4
| Mack Anthony P. (CEO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Bought 75,750 shares
@ $1.34, valued at
$101.5k
|
|
| 05/20/2022 |
4
| Floyd Eric (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Bought 4,479 shares
@ $1.3635, valued at
$6.1k
|
|
| 04/27/2022 |
4
| Bruce Gerald W (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 60,000 options to buy
@ $1.76, valued at
$105.6k
|
|
| 02/25/2022 |
4/A
| Gudin Jeffrey (Chief Medical Officer) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 60,676 options to buy
@ $2.13, valued at
$129.2k
|
|
| 02/25/2022 |
4/A
| Mack Anthony P. (CEO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 60,676 options to buy
@ $2.13, valued at
$129.2k
|
|
| 02/25/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Sendrow Jerrold (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 12,091 options to buy
@ $3.43, valued at
$41.5k
|
|
| 01/05/2022 |
4
| Jambulingam Thani (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 14,113 options to buy
@ $3.43, valued at
$48.4k
|
|
| 01/05/2022 |
4
| Singh Vanila (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 12,091 options to buy
@ $3.43, valued at
$41.5k
|
|
| 01/05/2022 |
4
| Dubin Michael F (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 12,091 options to buy
@ $3.43, valued at
$41.5k
|
|
| 01/05/2022 |
4
| Floyd Eric (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 15,124 options to buy
@ $3.43, valued at
$51.9k
|
|
| 01/05/2022 |
4
| JACOB GARY S (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 12,091 options to buy
@ $3.43, valued at
$41.5k
|
|
| 11/24/2021 |
4
| Sendrow Jerrold (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Bought 3,900 shares
@ $3.925, valued at
$15.3k
|
|
| 11/22/2021 |
4
| Mack Anthony P. (CEO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Bought 25,125 shares
@ $3.99, valued at
$100.2k
|
|
| 08/05/2021 |
4
| Dubin Michael F (Director) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 20,225 options to buy
@ $4.32, valued at
$87.4k
|
|
| 08/05/2021 |
3
| Bruce Gerald W (Director) has filed a Form 3 on Virpax Pharmaceuticals, Inc. |
|